GMAB.CO Genmab A/S | DK0010272202
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 33.177.152.250 | 28.246.393.520 | 17.46% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 107,03 | 75,30 | 42.13% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 13 | 13 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |